Cargando…

Immunotherapy for recurrent or metastatic vulvar carcinoma: A case report and review of current guidelines

There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease. In this case report, we present a patient with metastatic vulvar squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Praiss, Aaron, Navitski, Anastasia, Cohen, Seth, Tessier-Cloutier, Basile, Broach, Vance, O'Cearbhaill, Roisin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048086/ https://www.ncbi.nlm.nih.gov/pubmed/35496740 http://dx.doi.org/10.1016/j.gore.2022.100982

Ejemplares similares

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia
por: Freites-Martinez, Azael, et al.
Publicado: (2022)

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer
por: Navitski, Anastasia, et al.
Publicado: (2021)

Primary osteosarcoma of the uterus with cardiac and pulmonary metastases
por: Abraham, Cynthia, et al.
Publicado: (2014)

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer
por: Koneru, Mythili, et al.
Publicado: (2015)

A tale of two vulvar angiomyxomas: Two cases and review of literature
por: Navitski, Anastasia, et al.
Publicado: (2023)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer
por: Miller, Kathryn M., et al.
Publicado: (2021)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
por: Kyi, Chrisann, et al.
Publicado: (2021)

HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma
por: Lillsunde Larsson, Gabriella, et al.
Publicado: (2018)

Outcome of vulvar reconstruction in patients with advanced and recurrent vulvar malignancies
por: Zhang, Wei, et al.
Publicado: (2015)

Performance of the pattern‐based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma
por: Kortekaas, Kim E, et al.
Publicado: (2020)

ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies
por: Tessier-Cloutier, Basile
Publicado: (2023)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Society of Gynecologic Oncology Journal Club: Controversial conversations in Gynecologic cancer – The ABCs of ADCs (Antibody drug Conjugates)()
por: Martin, J., et al.
Publicado: (2023)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Recurrence of vulvar carcinoma: A multidisciplinary approach
por: Rei, M., et al.
Publicado: (2019)

Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]
por: Santin, Alessandro D., et al.
Publicado: (2020)

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
por: Rubinstein, Maria M., et al.
Publicado: (2023)

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
por: Mun, Sung Soo, et al.
Publicado: (2023)

Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR)
por: Nikolić, Olivera, et al.
Publicado: (2021)

Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal
por: Tessier-Cloutier, Basile, et al.
Publicado: (2019)

Quaternary and beyond cytoreduction: An updated and expanded analysis
por: Manning-Geist, Beryl L., et al.
Publicado: (2021)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
por: Crowley, Fionnuala, et al.
Publicado: (2022)

Second recurrence of aggressive vulvar angiomyxoma: a case report
por: Aminimoghaddam, Soheila, et al.
Publicado: (2023)

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
por: Friedman, Claire F., et al.
Publicado: (2023)

Vulvar Lichen Sclerosus: Current Perspectives
por: Krapf, Jill M, et al.
Publicado: (2020)

Simple and customizable method for fabrication of high-aspect ratio microneedle molds using low-cost 3D printing
por: Krieger, Kevin J., et al.
Publicado: (2019)

Metallic Microneedles for Transdermal Drug Delivery: Applications, Fabrication Techniques and the Effect of Geometrical Characteristics
por: Sargioti, Nikoletta, et al.
Publicado: (2022)

Vulvar Lichen Planus Presenting as Chronic Vulvar Purpura
por: Luzar, Boštjan, et al.
Publicado: (2023)

Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
por: Faraji, Farhoud, et al.
Publicado: (2023)

Recurrent vulvar melanoma invading urethra. Clinical case and literature review
por: Brasero Burgos, Jennifer, et al.
Publicado: (2018)

Recurrent vulvar breast fibroadenoma: presentation of a rare clinical condition
por: Li, Guanhua, et al.
Publicado: (2019)

Patología vulvar /
por: Lessana-Leibowith, Michéle

Vulvar myiasis.
por: Passos, M R, et al.
Publicado: (1998)

Vulvar Angioleiomyoma
por: Handler, Stephanie Jillian, et al.
Publicado: (2022)

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
por: Saito, Toshiaki, et al.
Publicado: (2017)

European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023
por: Oonk, Maaike H M, et al.
Publicado: (2023)

MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management
por: Miccò, Maura, et al.
Publicado: (2022)

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic
por: Lara, Olivia D., et al.
Publicado: (2022)

Interstitial high-dose-rate brachytherapy in locally advanced and recurrent vulvar cancer
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k9jfofjhc726varrepvv2ve7sh